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OBJECTIVES We designed a study to determine the carotid artery (CA) response to sympathetic activity
and to determine whether the response correlates with coronary risk and is independent of
wall thickness (IMT).
BACKGROUND Brachial artery reactivity in response to wall stress correlates with coronary risk and coronary
disease (CAD). The reactivity of the CA, which is susceptible to atherosclerosis, has not been
evaluated.
METHODS The change in diameter of the CA (DCAdiam) during a cold pressor test and after
nitroglycerin and IMT were measured with ultrasound in 93 men and women at average risk,
high risk and with CAD.
RESULTS At 90 s during a cold pressor test average-risk subjects increased CAdiam by 7.9 6 3.3%, which
was significantly less in the high-risk group (1.5 6 1.8%), and vasoconstriction occurred in
the group of subjects with CAD (26.9 6 2.7%) (p , 0.01 for comparisons). There were no
differences in response to nitroglycerin. Coronary risk was an independent predictor of the
%DCAdiam (p , 0.0001). Wall thickness, age, systolic pressure and triglycerides each
correlated negatively, and high-density lipoprotein cholesterol correlated positively with
%DCAdiam. The major variable associated with the %DCAdiam was group (p 5 0.0001). After
adjusting for smoking, age and high-density lipoprotein cholesterol, there was no association
between the %DCAdiam, and IMT and %DCAdiam, but not IMT, was predictive of groups.
CONCLUSIONS The CA response to a sympathetic stimulus is altered in the presence of coronary risk factors
and CAD and appears to reflect endothelial function independent of IMT. Carotid artery
reactivity may be a valuable adjunctive noninvasive method to assess coronary risk. (J Am
Coll Cardiol 2000;36:2192–7) © 2000 by the American College of Cardiology
The coronary artery response to increased flow, metabolic,
cholinergic and sympathetic signals is endothelium-
dependent and altered in the presence of atherosclerosis and
coronary risk factors (1–6). The brachial artery (BA) re-
sponse to shear stress induced by reactive hyperemia and
sympathetic stimuli is also dependent upon local endothelial
function (7,8), correlates with the presence of coronary risk
factors (9–13) and is abnormal in patients with coronary
artery disease (CAD) (14–16).
Carotid artery (CA) plaque and increasing wall thickness
(IMT) also correlate with coronary risk factors (17,18) and
the presence of CAD (19,20). Whether functional changes
in the human CA can be detected and whether they are
abnormal in the early stages of atherosclerosis has not been
previously reported. If CA reactivity is measurable and
independent of IMT, it may be a useful adjunctive tool for
the evaluation of novel risk factors, subclinical atheroscle-
rosis and response to therapeutic strategies.
We designed a study to determine the CA responsiveness
to the receptor-mediated sympathetic stimulus of cold in
healthy subjects, patients with risk factors for atherosclerosis
and documented coronary disease and whether the response
is independent of intima-media wall thickness (IMT). The
physiologic stress of a cold pressor test (CPT) was selected
because of the previously documented use in the evaluation
of coronary (4,21) and brachial endothelial-mediated reac-
tivity (13,16).
METHODS
Study recruitment and eligibility. Adult men and women
were recruited to be representative of average-risk, high-risk
and subjects with CAD. Average-risk was defined as #1
high-risk lipid parameter (high-density lipoprotein choles-
terol [HDL-C] , 0.9 mmol/L, low-density lipoprotein
cholesterol [LDL-C] $4.13 mmol/L or LDL-C/HDL-C
$4.5) with no other risk factors. High-risk was defined as at
least one coronary risk factor (smoking, family history of
premature CAD, hypertension) with at least one high-risk
lipid parameter and no symptoms or evidence of ischemia
on stress testing. Coronary artery disease was defined as
$50% stenosis in one or more major vessel on coronary
arteriography or a previously documented myocardial infarc-
tion.
Exclusion criteria included: coronary event within 12
weeks, heart failure, left ventricular ejection fraction , 40%,
diabetes, blood pressure . 160/90 mm Hg or left ventric-
ular hypertrophy, body mass index . 27.5 kg/m2, systemic
illness, average and high-risk subjects with plaque in the
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common CA or its branches and CAD subjects with plaque
(IMT . 1.3 mm) in the common CA.
Informed consent was obtained, and the study was
performed as approved by the Institutional Review Board of
the University of Michigan Health System. Studies were
performed fasting between 8 and 11 AM. Vasoactive sub-
stances were withheld for at least 12 h and vasoactive drugs
for 24 h.
B-mode ultrasound imaging. B-mode ultrasound scans
were obtained with a Biosound Phase II. The right common
CA was scanned by a technique previously standardized for
determining diameter, plaque and IMT (19,22). The plane
of maximal IMT was identified for each of six sites, near and
far wall of the internal carotid, bifurcation, and common
CA. Three sections of CA were defined by distance from
the flow divider: internal as the 1 cm above, bifurcation as
the 1 cm immediately below and common beginning at
1 cm and ending 2 cm below (22).
CPT and nitroglycerin (Ntg). A cold pressor test was
performed by submersion of the right foot to the ankle in
iced slush for 120 s, a modification from published methods
(13,16). The foot was chosen to maximize the hemody-
namic and sympathetic response (23,24). Subjects were
instructed to avoid breath holding, muscle contractions and
Valsalva’s maneuver. The response to 0.4 mg Ntg was used
as an indicator of endothelial-independent function (9).
Image analysis. Images were digitized utilizing a Macin-
tosh 7100/80 computer, Scion LG-3 frame grabber and
professional Panasonic-DS840 videotape with digital frame
storage. Wall thickness and diameters were measured uti-
lizing customized software. The mean common CA diam-
eter (CAdiam) was defined as the line identifying the
media-adventitia interface in the near to the far wall
calculated automatically by averaging measurements at
0.1 mm intervals over 1 cm. Wall thickness was defined as
IMT as previously described and validated (25,26). The
blood-intima and media-adventitia boundaries were traced
manually and automatically calculated as the average of
0.1 mm samples over 8 mm. The final average IMT for each
subject was calculated as the average thickness of six
segments.
The reproducibility of measuring the CAdiam and IMT
with our software is similar to published results (26,27). The
mean difference in diameter in 40 subjects obtained by the
same observer was 0.051 mm 6 0.039 mm and a coefficient
of variation (cv) 0.76%. The mean difference in IMT was
0.018 6 0.065 mm, cv 3.6%, and Pearson correlation
coefficient was 0.983, p 5 0.001.
Image selection. The response of conduit arteries to flow-
mediated shear stress or sympathetic stimuli has been shown
to be time-dependent (13,28). Because a primary objective
was to determine the normal response of the carotid artery
to CPT, we identified the time for 95% of the 26 average-
risk subjects to reach the peak change during and after CPT
and Ntg. Based on these observations, for subsequent
between group comparisons, we utilized the diameter
change from baseline to 90 s during CPT and 120 s after
Ntg.
Statistics. Continuous variables are presented as mean 6
standard deviation, and counts and percentages are given for
categorical variables. The Kruskal-Wallis test was used for
nonparametric distribution and pair-wise comparison by
Wilcoxon rank-sum test. The significance of a trend across
groups was tested using analysis of variance with Scheffe´ F
test to control for multiple stepwise comparisons. The
Spearman correlation coefficient was used to evaluate the
relationship between percent diameter change after CPT,
IMT and other coronary risk factors. Multiple linear regres-
sion analysis was used to identify independent factors
associated with percentage diameter change. Logistic re-
gression analysis was used to determine factors predictive of
groups. Statistical significance was accepted at the 95%
confidence interval (p , 0.05).
RESULTS
Clinical characteristics. The clinical characteristics of the
three groups are summarized in Table 1. As by definition
the lipid parameters differed significantly between average-
and high-risk. Twenty-one of the 37 high-risk and 18 of the
30 CAD subjects were taking lipid-lowering drugs.
Baseline diameters and IMT. The baseline CA diameters
and IMT are presented in Table 2. The trend to an increase
in diameter from average-risk to high-risk and high-risk to
CAD was not present after correction for body surface area
(BSA). The IMT was significantly greater in the CAD
group than it was in the average-risk group.
Hemodynamic monitoring. The hemodynamic response
to 120 s of CPT was similar to published reports and did not
differ between groups (23,24). There was a moderate in-
crease in systolic (23%), diastolic (18%) and mean pressure
(19%), heart rate (9%) and pressure rate product (32%).
There was no difference between groups in response to Ntg.
CA diameter response to CPT and Ntg. The change (D)
in CAdiam in response to CPT and Ntg is demonstrated in
Table 2 and Figure 1. There was a consistent and significant
increase in diameter during and after 120 s of CPT in
average-risk subjects. The maximal increment in diameter
occurred at 90 s during CPT (7.9 6 3.3%, p , 0.001 vs.
Abbreviations and Acronyms
BA 5 brachial artery
BSA 5 body surface area
CA 5 carotid artery
CAD 5 coronary artery disease
CAdiam 5 carotid artery diameter
CPT 5 cold pressor test
HDL-C 5 high-density lipoprotein cholesterol
IMT 5 wall thickness
LDL-C 5 low-density lipoprotein cholesterol
NO 5 nitric oxide
Ntg 5 nitroglycerin
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baseline) and did not change for 3 min after release.
Twenty-four of 26 (92%) average-risk subjects responded
with vasodilation, one with no change and one with a
0.25 mm decrease in diameter. An increase in diameter of at
least 0.22 mm or .3% was present in 75% of subjects.
In the high-risk subset, at 90 s of CPT, the mean change
in diameter was 1.5 6 1.8%, which differs from the
average-risk and CAD groups (p , 0.05). Thirty-two of the
37 high-risk subjects dilated or had no significant change,
range 0.03 mm to 0.35 mm. In the CAD group the response
was uniformly vasoconstriction. The mean decrease during
CPT was 0.52 6 0.2 mm or 26.9 6 2.7%, p , 0.01 versus
baseline and p , 0.01 versus the average-risk group (Table
2). All CAD subjects had a reduction in mean diameter at
90 s of CPT. There was no overlap between the 90 s
response in the CAD and the average-risk groups (Fig. 2).
The endothelium-independent increase in diameter from
baseline after Ntg in the 93 subjects was highly significant
and did not differ between groups (Fig. 2). The absolute and
percent responses to CPT and Ntg in the average-risk group
were highly correlated, r 5 0.78, p 5 0.0001.
Determinants of CA reactivity to CPT and IMT. The
determinants of percent change in diameter during CPT
(%DCAdiam) are presented in Table 3. The following were
entered for univariate analysis: %DCAdiam; BSA, the ratio of
diameter to BSA; age in years as a continuous variable and
a categorical value; gender; cholesterol; HDL-C; triglycer-
Table 1. Characteristics of the Study Population
Categorical
Average Risk
(n 5 26)
High Risk
(n 5 37)
CAD
(n 5 30)
Men 46% (12)* 76% (28) 74% (22)
Family Hx CAD 35% (9)† 73% (27) 60% (18)
Never smoked 65% (17) 51% (19) 50% (15)
Smoker 0% (0) 8% (3) 13% (4)
Estrogen use 8% (1) 11% (1) 50% (4)
Continuous p ANOVA
Age 53 6 11 a 44 6 10 c 58 6 9 0.0001
Men 46 6 9 b 42 6 6.2 c 58 6 9 0.0001
Women 59 6 9 49 6 17 57 6 7 0.1850
Systolic BP 122 6 15 126 6 14 133 6 17 0.0417
Diastolic BP 78 6 9 82 6 9 82 6 7 0.2493
Cholesterol 5.2 6 1.1 a 7.1 6 1.6 c 5.4 6 1.0 0.0001
Triglycerides 1.0 6 0.6 a,b 2.0 6 1 1.9 6 1.0 0.0014
HDL-C 1.5 6 0.5 a,b 1.1 6 0.3 1.0 6 0.3 0.0001
LDL-C 3.2 6 1.0 a 5.3 6 1.5 c 3.6 6 0.9 0.0001
Age in years, lipids in mmol/L (to convert to mg/dL multiply cholesterol by 38.7 and
triglyceride levels by 88.6), blood pressure in mm Hg.
Categorical: *p 5 0.01 average- vs. high-risk and CAD groups; †p 5 0.03 average-
vs. high-risk and CAD groups.
Continuous: p , 0.05 for a 5 average vs. high-risk; b 5 average vs. CAD; c 5
high-risk vs. CAD.
ANOVA 5 analysis of variance; BP 5 blood pressure; CAD 5 coronary artery
disease; HDL-C 5 high-density lipoprotein cholesterol; Hx 5 history of; LDL-C 5
low-density lipoprotein cholesterol.
Table 2. Baseline Carotid Artery Diameter, IMT and Response to CPT and Ntg
Measures in mm Average-risk (26) High-risk (37) CAD (30) p ANOVA
Diameter 6.92 6 0.68 7.14 6 0.50 7.43 6 0.71* 0.0119
Diameter/BSA 3.86 6 0.44 3.66 6 0.43 3.84 6 0.41 0.1239
IMT (mm) 0.62 6 0.11 0.66 6 0.27 0.78 6 0.11* 0.0001
DCAdiam CPT 90 s 0.56 6 0.25 a,b 0.10 6 0.14 c 20.52 6 0.20 0.0001
%DDCAdiam CPT 90 s 7.9 6 3.3% a,b 1.5 6 1.8% c 26.9 6 2.7% 0.0001
DCAdiam Ntg 0.54 6 0.18 0.59 6 0.21 0.51 6 0.18 0.2090
%DCAdiam Ntg 7.7 6 2.8% 8.2 6 3.1% 6.8 6 2.8% 0.1335
*p , 0.05 for average vs. CAD. Significance of trend expressed by ANOVA p value with Scheffe´ F test adjustment for
multiple comparisons. p , 0.01 for all between group comparisons: a 5 average vs. high-risk; b 5 average vs. CAD; c 5
high-risk vs. CAD.
ANOVA 5 analysis of variance; BSA 5 body surface area in kg/m2; CPT 5 cold pressor test; DCAdiam 5 change in carotid
artery diameter in mm; IMT 5 intima-media thickness.
Figure 1. Results in a 49-year-old man with CAD. (A) A 2.0% reduction
in cross-sectional diameter of the carotid artery occurs at 90 s of foot
submersion in ice slush. (B) A 5.84% increase in carotid diameter is
detected at 120 s after 0.4 mg of sublingual nitroglycerin. CAD 5 coronary
artery disease; CPT 5 cold pressor test; diam 5 diameter.
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ides; LDL-C; the ratio of LDL-C/HDL-C; baseline sys-
tolic, mean and diastolic blood pressures; family history;
ever smoked; current smoker; estrogen use and IMT.
There was a negative correlation between %DCAdiam and
baseline diameter (r 5 20.51, p 5 0.0001), which persisted
after correction for BSA (r 5 20.46, p 5 0.0001). There
was no difference in response to CPT based on gender,
estrogen use or BSA. The %DCAdiam was decreased in
subjects with a family history of CAD, previous and
current smokers, and it correlated negatively with age as a
continuous variable (r 5 20.29, p 5 0.004) and cut-points
of , or .40 (p 5 0.03), 50 (p 5 0.008) and 60
(p 5 0.0009) years. There was a highly significant
negative correlation of %DCAdiam with increasing IMT,
systolic blood pressure and triglycerides and a positive
correlation with HDL-C (Table 3). After correcting for age,
%DCAdiam remained significantly correlated with IMT,
HDL-C and triglycerides, but not systolic pressure.
Wall thickness increased significantly with age (r 5 0.60,
p 5 0.0001), systolic pressure (r 5 0.31, p 5 0.006) and
triglycerides (r 5 0.31, p 5 0.004) and correlated negatively
with HDL-C (r 5 20.24, p 5 0.03) but did not correlate
with gender, diastolic pressure, cholesterol, LDL-C or
LDL-C/HDL-C. After correcting for age, IMT remained
negatively correlated with HDL-C, positively correlated
with triglycerides and LDL-C/HDL-C and no longer
correlated with systolic pressure. The trend to increasing
IMT by group was significant, p analysis of variance
,0.0001, as were pair-wise differences between the average-
risk group versus the CAD group and the high-risk group
versus the CAD group (p , 0.05 for each).
When analyzed within each of the three groups,
%DCAdiam correlated negatively with age in the CAD
group only (r 5 20.34, p 5 0.04). There was no intragroup
correlation of DCAdiam with IMT or other risk factors. In
the average-risk group, IMT correlated highly with age (r 5
0.81, p 5 0.0001) and moderately with cholesterol, LDL-C
and triglycerides (p , 0.01 for each). In high-risk subjects,
IMT correlated only with age, and, for patients with CAD,
IMT correlated with age, diastolic pressure and triglycer-
ides.
Using general linear modeling, the major variable associ-
ated with %DCAdiam during CPT was group, F 5 162.5
Figure 2. Comparison of the change in carotid artery diameter in response to the cold pressor test and nitroglycerin in average-risk subjects , high-risk
subjects and subjects with CAD. Box with vertical lines 5 at 60 s of CPT; box with diagonal lines 5 120 s after Ntg. CAD 5 coronary artery disease;
CPT 5 cold pressor test; Ntg 5 nitroglycerin.
Table 3. Univariate Analysis Between Percent Change in
Carotid Artery Diameter During CPT, Carotid IMT and
Coronary Risk Factors
Parameters r Value p Value
93 patients IMT 20.43 0.0001
Age 20.29 0.004
Systolic BP 20.29 0.01
Triglycerides 20.24 0.03
HDL-C 10.23 0.04
Agerage-risk IMT 10.32 0.11
Age 10.39 0.05
High-risk IMT 10.14 0.46
Age 20.24 0.20
CAD IMT 20.14 0.40
Age 20.34 0.04
BP 5 blood pressure; CAD 5 coronary artery disease; CPT 5 cold pressor test;
HDL-C 5 high-density lipoprotein cholesterol; IMT 5 intima media thickness; r 5
Spearman’s correlation coefficient.
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(p 5 0.0001). With the combination of group, BSA, ever
smoked and IMT, the R2 is 0.92. We added “ever smoked”
and utilized multiple linear regression analysis to identify
independent factors associated with %DCAdiam without
consideration of group. In the final reduced model, age, ever
smoked and HDL-C were independently associated with
%DCAdiam, R
2 5 0.39. After adjusting for smoking, age
and HDL-C, there was no association between %DCAdiam
and IMT. When group remains in the model, age, group
and LDL-C remain highly significantly associated with
%DCAdiam (R
2 5 0.287) and unassociated with IMT. With
logistic regression analysis %DCAdiam, but not IMT, was
predictive of groups.
DISCUSSION
The common carotid artery in adults has a measurable
response to the sympathetic physiologic stress induced by
cold. Like the coronary and brachial artery, the carotid
response was anticipated to be the sum influence of a and b
adrenergic tone, with the latter dependent upon function of
the local endothelium (4,13,21). The normal response
during and up to 3 min after CPT was dilation. The
response was blunted or reversed in the presence of coronary
risk factors and coronary disease, respectively. That the
degree of vasodilation was significantly greater in the
average-risk group than it was in the high-risk group and
that vasoconstriction occurred in the CAD group is com-
parable to the coronary circulation (2,21,29,30) and BA
(13,16). The absence of a difference in response to Ntg and
the decreasing ratio of %DCAdiam CPT to %DCAdiam Ntg
supports the conclusion that the differences are predomi-
nantly related to endothelial function and not abnormalities
in smooth muscle responsiveness (7,8). Furthermore, the
correlation between reactivity to systemic cold and the
classic coronary risk factors of age, smoking, systolic pres-
sure and the lipoproteins LDL-C and HDL-C provide
internal validity that carotid vasoreactivity is a marker for
atherosclerosis risk.
While the reactivity of the CA in response to cold
correlated highly with IMT and shared risk factors, the
%DCAdiam to CPT was independent of IMT within a range
that is considered mildly increased (20). Additionally, in a
cohort of high-risk subjects with abnormal lipids and
subjects with CAD who had relatively normal lipids,
%DCAdiam was significantly better than IMT for distin-
guishing groups. Ghiadoni et al. (31) recently reported that,
in untreated hypertension, carotid IMT correlates inversely
with BA vasodilation to acetylcholine (r 5 0.58, p , 0.001).
The latter correlation is similar to our finding of an inverse
relationship between carotid IMT and %DCAdiam CPT,
r 5 20.496 and p 5 0.0001.
Because of accessibility and susceptibility to atheroscle-
rosis, the CA is particularly attractive as a clinical and
investigative tool. Both plaque and IMT correlate modestly
with risk factors and coronary disease (20,32), the response
to cholesterol lowering treatment (33,34) and coronary
event rates in longitudinal studies (33).
There have been no previous studies of carotid reactivity.
Previous reports considered larger conduit arteries less than
effective for determining endothelium-dependent reactivity.
Celermajer et al. (9) found the BA preferable to the femoral
artery because the degree of flow-mediated dilation was
inversely proportionate to the baseline diameter (9). How-
ever, the response of the CA to CPT in the average-risk
subjects in our study was considerably greater and less
dependent on age and gender than that reported in the BA
by Corretti et al. (13) (CA 7.91 6 3.33% vs. BA 1.4 6
2.5%). Furthermore, in 10 subjects we found the repeatabil-
ity of measuring the larger CA to be better than that of the
BA (variability of baseline study 1 vs. study 2, carotid
0.07 6 0.07 mm vs. brachial 0.19 6 0.12, p 5 0.0001).
The decrease in vasodilation of the CA in response to
CPT in the high-risk and CAD groups is consistent with
both human and animal experimental evidence. The re-
sponse of conduit arteries to systemic cold is the result of the
balance between adrenergic vasoconstriction and vasodila-
tion, with the latter mediated by endothelial function
(2,4,13,21,35). The normal coronary vasodilator response to
CPT can be blocked by competitive inhibition of
L-arginine, a substrate for nitric oxide (NO) synthase (36),
and L-arginine can normalize the vasoconstrictor response
to CPT in CAD (37). Both endogenous NO and exog-
enously administered NO donors suppress sympathetic
outflow at the prejunctional level, and NO may exert a tonic
influence on the discharge of sympathetic efferents (38–40).
Study limitations. Our study supports a role for carotid
vasoreactivity in the assessment of atherosclerotic risk fac-
tors. While the CAD subjects were older and could have
influenced the ability to discriminate groups by %DCAdiam
during CPT, there was no overlap between the response in
the average-risk and CAD subjects who were of comparable
age. To further assess the significance of age, we analyzed 66
additional patients (total 157 subjects with 31 average-risk,
79 high-risk and 49 subjects with CAD) and found com-
parable results. The change in diameter during CPT re-
vealed a strong age to HDL-C interaction and no quadratic
age effect.
Conclusions. The direction and magnitude of change in
the CAdiam during and after the sympathetic stress induced
by foot submersion in ice slush is altered based upon the
presence of risk factors and coronary disease. The data
suggest that the response reflects local endothelial function
and is independent of IMT. Carotid reactivity in response
to CPT (and possibly other stressors) may have a valuable
role in coronary risk assessment and response to therapy.
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